Bovine Mastitis Market
Report ID: SQMIG35I3024
Report ID: SQMIG35I3024
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35I3024 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
172
|Figures:
79
Global Bovine Mastitis Market size was valued at USD 1.87 Billion in 2024 and is poised to grow from USD 1.99 Billion in 2025 to USD 3.22 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
The global bovine mastitis market covers products and services that are meant to prevent, identify, and manage inflammation of the udder in dairy cattle. This issue drags down milk output, affects animal welfare in a real way, and bumps up production expenses, so for many dairy operators it is a big deal everywhere. Right now, North America and Europe still take the lead in consumption, but there is Brazil, India, and other emerging economies pushing harder as herd numbers climb, and as export rules get stricter.
One major factor steering the global bovine mastitis market growth is that more farms are adopting precision‑dairy tools, the ones that mix sensor readings with analytics so mastitis shows up earlier. So when a cow’s somatic‑cell count shifts, or the temperature strays from its usual range, the algorithms throw out an alert. Then dairies can do targeted treatment fast, which often cuts back antibiotic use and reduces milk discard. That practical efficiency becomes attractive for operations that need to satisfy tough quality expectations, for example ISO 22000. Because of this, there’s growing demand for integrated bundles—think hardware, software, and ongoing support all together. As a result, businesses that link up with veterinary networks and offer subscription‑style monitoring platforms tend to gain faster revenue. Meanwhile, smaller farms can sometimes access cheaper mobile applications, where complex information gets translated into simple on‑farm actions, not just raw charts nobody wants to interpret.
AI‑driven diagnostics are reshaping bovine mastitis market outlook by allowing fast, on‑farm detection using sensor‑based somatic cell count analysis plus image recognition algorithms. These setups can work alongside automated milking systems, so farmers get real‑time warnings and they can separate the cow early before obvious clinical signs even show up. Earlier action means lower treatment costs, less antibiotic reliance, and better milk quality, and that combination usually boosts herd profitability too. In addition, the tech produces continuous data streams, which are useful for predictive modeling. That helps producers anticipate likely outbreaks and tune preventive plans before problems escalate. And as more dairy operations roll out these intelligent systems, market demand increases not only for the precision health solutions themselves, but also for the connected services around them, like installation, monitoring, and support.
Market snapshot - (2026-2033)
Global Market Size
USD 1.87 Billion
Largest Segment
Antibiotics
Fastest Growth
Vaccines
Growth Rate
6.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global bovine mastitis market is segmented by product type, mastitis type, route of administration, end user, animal type, distribution channel and region. Based on product type, the market is segmented into Antibiotics, Vaccines, Diagnostic Products and Others. Based on mastitis type, the market is segmented into Clinical Mastitis and Subclinical Mastitis. Based on route of administration, the market is segmented into Intramammary Administration, Injectable Administration, Oral Administration and Others. Based on end user, the market is segmented into Dairy Farms, Veterinary Clinics, Animal Hospitals and Others. Based on animal type, the market is segmented into Lactating Cattle and Dry Cattle. Based on distribution channel, the market is segmented into Veterinary Pharmacies, Farm Supply Stores and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the bovine mastitis market analysis, the Antibiotics segment dominates because it goes right at the primary cause of mastitis, bacterial infection, which still is the most urgent clinical concern for dairy producers. Veterinarians and farm managers tend to lean on proven efficacy, established dosing routines,and immediate therapeutic results, so antibiotics become the go-to choice for clinical as well as subclinical cases. That long held trust, plus regulatory clearances and broad availability, keeps it in the leading position in the market overall, today globally now.
However, the Vaccines sub-segment is the one that appears to expand the fastest because prevention is getting more traction among dairy operations that want to lower antibiotic reliance. Things like recombinant technology improvements, broader spectrum coverage, and policy incentives are pushing adoption forward, so vaccines start to look like a catalyst for sustainable mastitis control and market growth.
According to the bovine mastitis market forecast, the Intramammary Administration segment takes the lead because it places therapeutics straight into the infected udder quarters. As a result, high local concentration and rapid pathogen elimination offered. This targeted delivery cuts down systemic exposure too, tends to shorten withdrawal times, and fits well with everyday farm handling routines, so it’s often the preferred approach for both acute and chronic situations. Its practical use and proven results, keep it firmly ahead across dairy operations during the full production cycle, even with different herd management regimes globally.
Whereas the oral administration segment is expected to hold the largest bovine mastitis market share because it’s easier to use, allows a convenient dosing routine, and also fits well with what most farms do day to day. Newer drug formulations have improved bioavailability and overall treatment effectiveness, so oral products are becoming more dependable. At the same time, there’s more focus on animal welfare, less handling stress on the animals, and a stronger move toward large-scale livestock management, all of which help adoption. Together, they keep boosting the segment's presence across veterinary healthcare markets.
To get detailed segments analysis, Request a Free Sample Report
As per the bovine mastitis market regional forecast, North America thrives on a mature dairy setup where cutting edge biotechnology meets strong veterinary networks. Solid research institutions are pushing steady improvements in diagnostic kit design, vaccine development, and therapeutic formulations, while regulatory rules keep leaning hard on animal health plus food safety, which helps advanced treatment protocols get adopted fast, without too much fuss. At the same time, industry partners use well organized cooperative extensions and ongoing farmer education, so best‑practice implementation stays consistent across a lot of herd sizes, from small operations up through big ones. Supply chains are also tightly coordinated, linking manufacturers, distributors, and dairy producers with very little friction, and that basically speeds up product rollout. And, since major multinational agribusinesses show up with capital and know how, long term development becomes easier, so North America ends up looking like a benchmark for quality and efficiency in mastitis management.
United States Bovine Mastitis Market
In the United States, the Bovine Mastitis sector is boosted by intensive research partnerships, especially between university veterinary schools and private biotech firms, which feeds a steady pipeline of new antimicrobial and immunomodulatory solutions. Adoption is helped a lot by on farm digital monitoring tools that catch issues early, and then allow more targeted therapy, which in turn lowers disease prevalence. Extension services are also fairly comprehensive, guiding dairy producers on biosecurity protocols, and the distribution network is well established, so products show up on time for both large scale farms and family run operations.
Canada Bovine Mastitis Market
In Canada, the Bovine Mastitis industry is more or less defined by a united strategy that mixes governmental animal health initiatives with industry led innovation. Provincial dairy boards promote best‑practice guidelines, and that encourages broad uptake of evidence based treatment regimens. Research organizations within Canada keep working on vaccines and diagnostic platforms that fit local needs, which matches the country’s focus on sustainable dairy production. Cold‑chain logistics are efficient, and veterinarians plus producers collaborate closely, so outbreaks can be met faster, and overall market resilience stays stronger.
The European bovine mastitis market penetration is driven by strict animal welfare legislation, it basically forces proactive health monitoring and quick intervention whenever mastitis shows up. Cross border research consortia also bring together know how, so scientific progress speeds up, especially for next generation therapeutics and precision diagnostic tools suited to different dairy systems. Consumers wanting high quality, safe dairy products pushes producers toward integrated herd health programs, and those programs get supported by more sophisticated data analytics. Regulatory standards across member states are more harmonized, so product approvals and market entry move faster, and investment from established firms plus newer entrants becomes easier. On top of that, public private partnerships fund sustainability efforts, and mastitis control gets embedded into wider environmental and animal health agendas, which keeps Europe positioned as a leader in responsible dairy farming.
Germany Bovine Mastitis Market
The Germany’s Bovine Mastitis Market is helped by a thick network of research universities and biotech clusters, with attention placed on inventive treatment options and faster diagnostic methods. The German dairy industry leans into precision farming technologies, letting farms detect problems early and shift to targeted therapy, and that fits the national quality standards. Funding from government sources backs collaborative projects that combine antimicrobial stewardship with herd health management, so market depth grows and product variety expands too.
United Kingdom Bovine Mastitis Market
In the United Kingdom, the Bovine Mastitis Market is seeing quicker expansion because digital health platforms are being adopted more vigorously, these tools support real time monitoring of udder health. Academia and industry collaborate strongly to develop new vaccines and biologics, and regulatory pathways are proactive enough to keep market access moving relatively swiftly. Extension services also keep emphasizing preventive hygiene practices, so dairy farms can lower incidence rates, and that naturally expands demand for more advanced therapeutic solutions.
France Bovine Mastitis Market
The France’s Bovine Mastitis Market is becoming a focal point for sustainable dairy efforts, especially where low-impact treatment strategies matter, and where organic-compatible products are expected. French research institutes are looking into phytogenic alternatives and immunostimulants, which aligns with a market that values more “natural” style solutions. Regional veterinary networks working closely with dairy cooperatives help spread best practice guidelines quickly, keeping steady adoption going.
Asia Pacific is moving up fast in its role by modernizing dairy operations, and also by folding in more advanced disease management technologies, it’s not just one thing. The government rules are pushing money toward better veterinary infrastructure ,and they also make it easier to adopt high efficiency milking setups that come with automated mastitis detection sensors. Since dairy consumption keeps climbing, producers are more and more focused on herd well‑being, so they start working with multinational manufacturers to adapt advanced therapeutic and diagnostic products for local needs. There are also knowledge transfer efforts, plus farmer training programs, that boost expertise. Meanwhile, regional trade agreements help with cross border sharing of innovations, so the whole cycle keeps going. With this mix of policy backing, tech take up, and market pressure, Asia Pacific is becoming a more influential force in global mastitis solutions.
Japan Bovine Mastitis Market
The Bovine Mastitis Market in Japan feels very centered on precision veterinary care, with a lot of adoption of automated somatic cell count monitoring, and also quick on farm testing kits. Japanese dairy players rely on tight partnerships with research organizations ,so they can craft vaccine formulations that fit the bacterial strains that show up most often. On top of that, government subsidies for high tech farm equipment keep encouraging farms to integrate advanced mastitis management solutions, which strengthens the market’s momentum.
South Korea Bovine Mastitis Market
The Bovine Mastitis Market in South Korea is powered by a bold modernization push across dairy farms, including IoT enabled sensors that keep streaming udder health information continuously. Joint work between domestic biotech companies and larger global pharmaceutical groups speeds up the arrival of newer antimicrobial products and immunotherapies. National animal health programs also back stricter hygiene procedures, plus ongoing farmer education, and that combination builds a good base for steady market growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Market Demand For Milking Solutions
Increasing Adoption Of Precision Farming
High Cost Of Diagnostic Equipment
Regulatory Complexity Across Regions
Request Free Customization of this report to help us to meet your business objectives.
The global bovine mastitis market feels very much like a chessboard, where new technology-driven players keep showing up and teaming up with others; they’re using advanced detection tools and then extending distribution reach so dairy producers can get what they want: fast, accurate diagnostics. Meanwhile, the older companies sit back a bit, then go for acquisitions, joint ventures, and all that, to widen their product line and get into more regions. Lately, there were a few partnerships where diagnostic device manufacturers work with dairy cooperatives to roll on-farm testing into everyday operations, and there’s also M&A chatter focused on bringing together antimicrobial and vaccine options.
Top Player’s Company Profile
Recent Developments in the Bovine Mastitis Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, as for the global bovine mastitis market, it’s pushed mostly by the growing demand for milking solutions that promise high quality, antibiotic‑free milk, so producers start investing in early detection and treatment technologies. a second push is the fast adoption of precision‑farming tools that provide udder health information in real time, and then allow targeted interventions. The whole market gets held back by the expensive cost of diagnostic equipment, and that makes adoption harder for small scale farms. North America is still the leading region, largely because it has a mature dairy industry, broad research networks and distribution channels that are fairly well aligned. In product share terms, antibiotics remain the top segment, mainly because they have proven efficacy and are widely available.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.87 Billion |
| Market size value in 2033 | USD 3.22 Billion |
| Growth Rate | 6.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Bovine Mastitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bovine Mastitis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bovine Mastitis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Bovine Mastitis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Bovine Mastitis Market size was valued at USD 1.87 Billion in 2024 and is poised to grow from USD 1.99 Billion in 2025 to USD 3.22 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
The competitive landscape of the global bovine mastitis market is shaped by technology‑driven entrants and strategic collaborations, with firms leveraging advanced detection platforms and expanding distribution networks to capture dairy producers’ demand for rapid, accurate diagnostics, while incumbents pursue acquisitions and joint ventures to broaden product portfolios and geographic reach. Recent moves include partnerships between diagnostic device manufacturers and dairy cooperatives to integrate on‑farm testing, and M&A activity aimed at consolidating antimicrobial and vaccine offerings. 'Zoetis Inc.', 'Merck Animal Health', 'Elanco Animal Health Incorporated', 'Boehringer Ingelheim Animal Health', 'Ceva Santé Animale', 'Virbac S.A.', 'Vetoquinol S.A.', 'Dechra Pharmaceuticals PLC', 'HIPRA S.A.', 'Phibro Animal Health Corporation', 'Norbrook Laboratories Limited', 'Indian Immunologicals Limited', 'Hester Biosciences Limited', 'Biogenesis Bago S.A.', 'Bimeda Holdings PLC', 'Neogen Corporation', 'IDEXX Laboratories, Inc.', 'LABORATORIOS CALIER, S.A.', 'Inovet Group', 'Kyoritsu Seiyaku Corporation'
Consumers increasingly expect high‑quality, antibiotic‑free dairy products, prompting dairy producers to implement robust mastitis control programs. Early detection technologies enable timely treatment, reducing infection severity and preserving milk yield. As farms seek to maintain competitive advantage and meet quality standards, demand for advanced diagnostic kits and automated monitoring systems rises, driving market expansion. The emphasis on animal welfare further encourages investment in preventive solutions, reinforcing the growth trajectory of the bovine mastitis sector. Moreover, industry collaborations facilitate knowledge sharing and accelerate technology adoption.
Precision Dairy Management: The dairy sector is rapidly integrating precision‑farming tools, such as on‑farm sensors, real‑time milk analyzers, and cloud‑based data platforms, to monitor udder health continuously. By converting physiological signals into actionable alerts, producers can intervene at the earliest signs of inflammation, reducing reliance on reactive treatments. This data‑driven approach also supports customized milking protocols and herd‑level benchmarking, fostering higher cure rates, lower culling, and improved milk quality, and aligning with sustainability goals, and strengthening overall herd profitability through better resource allocation.
Why does North America Dominate the Global Bovine Mastitis Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
